These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5971801)
1. Isolation and antileukemic activity, in mice, of 1-beta-D-arabinofuranosylcytosine 5'-phosphate present in synthetic 5'-cytidylic acid. Schrecker AW; Mead JA; Urshel MJ Biochem Pharmacol; 1966 Oct; 15(10):1443-52. PubMed ID: 5971801 [No Abstract] [Full Text] [Related]
2. Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine. Kodama K; Morozumi M; Saitoh K; Kuninaka A; Yoshino H; Saneyoshi M Jpn J Cancer Res; 1989 Jul; 80(7):679-85. PubMed ID: 2507491 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells. Shrecker AW; Urshel MJ Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066 [No Abstract] [Full Text] [Related]
4. Letter: Proposed new derivative of cytosine arabinoside (NSC-63878) to circumvent resistance. Cysyk RL Cancer Chemother Rep; 1974; 58(3):298-9. PubMed ID: 4842665 [No Abstract] [Full Text] [Related]
5. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine. Khwaja TA; Kigwana LJ; Mian AM Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296 [No Abstract] [Full Text] [Related]
6. 2'-O-nitro-1-beta-D-arabinofuranosylcytosine. A new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity. Chwang TL; Fridland A; Avery TL J Med Chem; 1983 Feb; 26(2):280-3. PubMed ID: 6827546 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice. Neil GL; Wiley PF; Manak RC; Moxley TE Cancer Res; 1970 Apr; 30(4):1047-54. PubMed ID: 5504347 [No Abstract] [Full Text] [Related]
8. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)]. Takenaka T; Kimura K Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176 [No Abstract] [Full Text] [Related]
9. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules. Kline I; Venditti JM; Tyrer DD; Goldin A Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445 [No Abstract] [Full Text] [Related]
10. Studies on biologically active nucleosides and nucleotides. 5. Synthesis and antitumor activity of some 2,2'-anhydro-1-(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine salts and 2,2'-anhydro-1-(3'-O-acyl-beta-D-arabinofuranoxyl)cytosine 5'-phosphates. Kondo K; Nagura T; Arai Y; Inoue I J Med Chem; 1979 Jun; 22(6):639-46. PubMed ID: 458820 [TBL] [Abstract][Full Text] [Related]
11. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea. Tyrer DD; Kline I; Venditti JM; Goldin A Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252 [No Abstract] [Full Text] [Related]
12. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210. Vadlamudi S; Goldin A Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846 [No Abstract] [Full Text] [Related]
13. Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine. Wang MC; Sharma RA; Bloch A Cancer Res; 1973 Jun; 33(6):1265-71. PubMed ID: 4578070 [No Abstract] [Full Text] [Related]
14. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies. Dollinger MR; Burchenal JH; Kreis W; Fox JJ Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789 [No Abstract] [Full Text] [Related]
15. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative. Kato Y; Saito M; Fukushima H; Takeda Y; Hara T Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162 [TBL] [Abstract][Full Text] [Related]
16. [Antileukemic activity of liposome forms of cytosine arabinoside and cyclocytidine]. Reshchikov VP; Afonin NI; Ermakov LN; Fertukova NM; Oksinoĭd OE Gematol Transfuziol; 1984; 29(5):49-51. PubMed ID: 6203808 [No Abstract] [Full Text] [Related]
17. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation. Durham JP; Ives DH Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509 [No Abstract] [Full Text] [Related]
18. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine. Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182 [TBL] [Abstract][Full Text] [Related]
19. Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210. Caron N; Lee SH; Kimball AP Cancer Res; 1977 Sep; 37(9):3274-9. PubMed ID: 884674 [TBL] [Abstract][Full Text] [Related]
20. Nucleic acids. 11. Synthesis of 5'-esters of 1-beta-D-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity. Gish DT; Kelly RC; Camiener GW; Wechter WJ J Med Chem; 1971 Dec; 14(12):1159-62. PubMed ID: 5116227 [No Abstract] [Full Text] [Related] [Next] [New Search]